“More than 90% of our research is already based on precision medicine”
Innovation is rapidly transforming healthcare, opening new opportunities for patients and health systems. Marta Moreno, Vice President of Corporate Affairs and Market Access at AstraZeneca Spain, analyzes the role of science, Spain’s positioning, and the challenges of access to new treatments.